1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MODERNA INC
Moderna Inc XNAS: MRNA

Moderna Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. ...

Read More
24.84 0.96 (4.02%)
67.04% Fall from 52W High
15.6M
XNAS Volume

XNAS 16 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Moderna Inc is on 25 Sep 2025 for the purpose of Bernstein Insights: Healthcare Leaders and Disruptors See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
24.8 / 100
Momentum Score
Technically Neutral
37.2 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
44
1Yr Price target upside is 78%
20 analysts

8

S

19

W

2

O

2

T

SWOT Analysis

Moderna Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..